Bumpus Namandje
Director at RXRX
- Sold, on record
- $28k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jun 18, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- RXRXRECURSION PHARMACEUTICALS, INC.Director
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice RXRXNoticeJun 3, 2026 2026
Filed to sell 4,386 shares ($16k)
Bumpus Namandje, Director
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale RXRXRoutineJun 3, 2026 same day
Sold 4,386 shares at $3.54 ($16k)
Bumpus Namandje, Director
10b5-1 planSold 9.2% of holdings ($168k position)43,171 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice RXRXNoticeJun 18, 2026 +15 days
Filed to sell 3,963 shares ($13k)
Bumpus Namandje, Director
10b5-1 planFiling
- 4 Form 4 sale RXRXRoutineJun 18, 2026 same day
Sold 3,963 shares at $3.18 ($13k)
Bumpus Namandje, Director
10b5-1 planSold 3% of holdings ($418k position)127,632 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Jun 22, 2026 | RXRX | Director | Form 4 sale | 3,963 | $13k | 3.0% | Routine | SEC |
| Jun 18, 2026 | Jun 18, 2026 | RXRX | Director | Form 144 notice | 3,963 | $13k | Notice | SEC | |
| Jun 3, 2026 | Jun 4, 2026 | RXRX | Director | Form 4 sale | 4,386 | $16k | 9.2% | Routine | SEC |
| Jun 3, 2026 | Jun 3, 2026 | RXRX | Director | Form 144 notice | 4,386 | $16k | Notice | SEC |